NCT03833895View on ClinicalTrials.gov

The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

February 20, 2019

Primary Completion Date

September 1, 2019

Study Completion Date

September 2, 2019

Conditions
Cesarean Section Complications
Interventions
DRUG

Norepinephrine

0.05ug/kg/min Norepinephrine during Cesarean Section Operation

DRUG

Phenylephrine

0.25ug/kg/min phenylephrine during Cesarean Section Operation

DRUG

Ringer's Solution

3 ml/kg/min of LR was administrated according to standard weight.

Trial Locations (1)

100053

Xuanwu Hospital, Beijing

All Listed Sponsors
lead

China International Neuroscience Institution

OTHER

NCT03833895 - The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section | Biotech Hunter | Biotech Hunter